New Vaccine Post-Introduction Evaluation - libdoc.who.int - World ...

More documents

Recommendations

Info

WHO/IVB/10.03 ORIGINAL: ENGLISH New Vaccine Post-Introduction Evaluation (PIE) Tool Immunization, Vaccines and Biologicals
The Department of Immunization, Vaccines and Biologicals thanks the donors whose unspecified financial support has made the production of this document possible. This publication was produced by the Expanded Program on Immunization (EPI) of the Department of Immunization, Vaccines and Biologicals Ordering code: WHO/IVB/10.03 July 2010 This publication is available on the Internet at: www.who.int/vaccines-documents/ Copies of this document as well as additional materials on immunization, vaccines and biologicals may be requested from: World Health Organization Department of Immunization, Vaccines and Biologicals CH-1211 Geneva 27, Switzerland • Fax: + 41 22 791 4227 • Email: vaccines@who.int • © World Health Organization 2010 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 3264; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. The named authors alone are responsible for the views expressed in this publication. Printed by the WHO Document Production Services, Geneva, Switzerland ii
Page 1: WHO/IVB/10.03 ORIGINAL: ENGLISH New
Page 5 and 6: 5. Appendices......................
Page 7 and 8: Acknowledgements This Post-Introduc
Page 9 and 10: viii
Page 11 and 12: 1.3 What is a PIE? A PIE is a post-
Page 13 and 14: Table 2: Example of data and docume
Page 15 and 16: When in the field, teams should ide
Page 17 and 18: 2. Evaluation areas Data are collec
Page 19 and 20: Coverage The primary indicator of v
Page 21 and 22: 2.3 Cold-chain management Some vacc
Page 23 and 24: 2.5 Monitoring and supervision A fi
Page 25 and 26: 2.8 Vaccine wastage Wastage, partic
Page 27 and 28: 3. Data synthesis and reporting A l
Page 29 and 30: 4. Reference documents / websites
Page 31 and 32: Appendix 2: Questionnaires Layout a
Page 33 and 34: Appendix 2.1: Questionnaire — cen
Page 35 and 36: Abbreviation ROTA GEN 11. Is there
Page 37 and 38: Abbreviation CENT/REG GEN GEN GEN G
Page 39 and 40: Abbreviation GEN GEN GEN PENTA PENT
Page 41 and 42: Abbreviation CENT CENT CENT C&R SUS
Page 43 and 44: Abbreviation GEN GEN GEN For vaccin
Page 45 and 46: Abbreviation GEN GEN GEN 1. Were yo
Page 47 and 48: Abbreviation GEN GEN 15. Have immun
Page 49 and 50: Abbreviation GEN GEN WASTE MANAGEME
Page 51 and 52: Abbreviation ROTA ROTA PENTA GEN GE
Page 53 and 54:
Abbreviation GEN 64. Are appropriat
Page 55 and 56:
Appendix 2.3: Questionnaire — mot
Page 57 and 58:
Appendix 4: Summary spreadsheet Sum
Page 59 and 60:
Level Question Central Regional Reg
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Appendix 5: Summary spreadsheet Sum
Page 69 and 70:
Advocacy, Communication and Accepta
Page 71 and 72:
Appendix 6: Common problems and sol
Page 73 and 74:
Scenario Over- or under-stock of va
Page 75 and 76:
66 New Vaccine Post-Introduction Ev
show all

New Vaccine Post-Introduction Evaluation - libdoc.who.int - World ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?